Husemoen LLN - Search Results

1

Safety and glycemic control with insulin degludec use in clinical practice: results from a 3-year Japanese post-marketing surveillance study.

Murata T, Husemoen LLN, Nemoto S, Matsuhisa M. Murata T, et al. Among authors: husemoen lln. Diabetol Int. 2023 Aug 18;15(1):76-85. doi: 10.1007/s13340-023-00657-7. eCollection 2024 Jan. Diabetol Int. 2023. PMID: 38264229

2

Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort.

Thorius IH, Husemoen LLN, Nordsborg RB, Alibegovic AC, Gall MA, Petersen J, Damm P, Mathiesen ER. Thorius IH, et al. Among authors: husemoen lln. Diabetes Care. 2024 Mar 1;47(3):384-392. doi: 10.2337/dc23-1281. Diabetes Care. 2024. PMID: 38128075

3

Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study.

Verma S, Alamuddin N, Alawadi F, Alkandari H, Almahmeed W, Assaad-Khalil SH, Haddad J, Husemoen LLN, Lombard L, Malik RA, Mashaki Ceyhan E, Sabbour H, Tombak G, Yadav G, Salek S. Verma S, et al. Among authors: husemoen lln. Circulation. 2023 Apr 18;147(16):1251-1255. doi: 10.1161/CIRCULATIONAHA.123.064345. Epub 2023 Mar 6. Circulation. 2023. PMID: 36877670 Free PMC article. No abstract available.

4

Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study.

Thorius IH, Husemoen LLN, Nordsborg RB, Alibegovic AC, Gall MA, Petersen J, Mathiesen ER. Thorius IH, et al. Among authors: husemoen lln. Diabetologia. 2023 May;66(5):826-836. doi: 10.1007/s00125-022-05864-6. Epub 2023 Jan 14. Diabetologia. 2023. PMID: 36640191

5

Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study.

Lane W, Faurby M, Husemoen LLN, Markovich DL, Rathor N, De Block C. Lane W, et al. Among authors: husemoen lln. Diabetes Ther. 2021 Dec;12(12):3067-3077. doi: 10.1007/s13300-021-01165-0. Epub 2021 Oct 12. Diabetes Ther. 2021. PMID: 34637112 Free PMC article.

6

Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: A population-based observational retrospective cohort study.

Khunti K, Hertz CL, Husemoen LLN, Mocevic E, Nordsborg RB, Piltoft JS, Bain SC. Khunti K, et al. Among authors: husemoen lln. Diabet Med. 2022 Mar;39(3):e14697. doi: 10.1111/dme.14697. Epub 2021 Oct 2. Diabet Med. 2022. PMID: 34558105 Free PMC article.

7

Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study.

Mathiesen ER, Ali N, Alibegovic AC, Anastasiou E, Cypryk K, de Valk H, Dores J, Dunne F, Gall MA, Garcia SD, Hanaire HP, Husemoen LLN, Ivanišević M, Kempe HP, McCance DR, Damm P. Mathiesen ER, et al. Among authors: husemoen lln. Diabetes Care. 2021 Sep;44(9):2069-2077. doi: 10.2337/dc21-0472. Epub 2021 Jul 30. Diabetes Care. 2021. PMID: 34330786 Free PMC article.

8

Characteristics of pregnant women with diabetes using injectable glucose-lowering drugs in the EVOLVE study.

Mathiesen ER, Ali N, Anastasiou E, Cypryk K, de Valk HW, Dores JM, Dunne FP, Ekelund M, Durán García S, Hanaire H, Husemoen LLN, Ivanisevic M, Kempe HP, Nordsborg RB, McCance DR. Mathiesen ER, et al. Among authors: husemoen lln. J Matern Fetal Neonatal Med. 2022 Dec;35(25):7992-8000. doi: 10.1080/14767058.2021.1940132. Epub 2021 Jun 28. J Matern Fetal Neonatal Med. 2022. PMID: 34182866

9

All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK.

Husemoen LLN, Mørch LS, Christensen PK, Hartvig NV, Feher MD. Husemoen LLN, et al. Diabetes Ther. 2021 May;12(5):1299-1311. doi: 10.1007/s13300-021-01048-4. Epub 2021 Mar 15. Diabetes Ther. 2021. PMID: 33721211 Free PMC article.

10

Understanding Patients' Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market.

Murthy S, Aneja P, Asirvatham AJ, Husemoen LLN, Rhee NA, Kesavadev J. Murthy S, et al. Among authors: husemoen lln. Pharmacoecon Open. 2021 Jun;5(2):261-273. doi: 10.1007/s41669-020-00246-3. Epub 2021 Jan 6. Pharmacoecon Open. 2021. PMID: 33410093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page